In vitro and in vivo activity of a hypotoxic copper(I) complex against dermotropic Leishmania species

ABSTRACT Cutaneous leishmaniasis is a disease caused by protozoa of the genus Leishmania and, currently, the treatment of first choice is meglumine antimoniate. However, due to its limited effectiveness and high toxicity, it is necessary to seek new active principles for leishmaniasis treatment. Met...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHAGAS, Ana Flávia da Silva, PORCHIA, Marina, NASCIMENTO, Thaís Pinto, CORREA, Carolina Nunes Souza, BRASIL, Anny Maíza Vargas, FRANCO, Antonia Maria Ramos
Format: Dataset
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHAGAS, Ana Flávia da Silva
PORCHIA, Marina
NASCIMENTO, Thaís Pinto
CORREA, Carolina Nunes Souza
BRASIL, Anny Maíza Vargas
FRANCO, Antonia Maria Ramos
description ABSTRACT Cutaneous leishmaniasis is a disease caused by protozoa of the genus Leishmania and, currently, the treatment of first choice is meglumine antimoniate. However, due to its limited effectiveness and high toxicity, it is necessary to seek new active principles for leishmaniasis treatment. Metal complexes are gaining importance due to their effectiveness and low toxicity. In this context, the present study aimed to evaluate the in vitro and in vivo antileishmanial activity of the hypotoxic copper(I) complex [HB(pz)3]Cu(PCN). Four dermotropic species of Leishmania were tested with the metal complex and its effectiveness was determined through parasitic viability and infectivity rate, and cytotoxicity was determined using a redox dye (resazurin). For the in vivo tests, hamsters were infected and the lesions treated with a formulated ointment containing the complex, the effectiveness of which was assessed by measuring the diameter of the inoculum/snout location and determining the parasitic load. The results demonstrated moderate toxicity in murine macrophages and human monocytes and better efficacy in Leishmania (V.) braziliensis when compared to the other species tested, with a 50% reduction in the viability of promastigote and amastigote forms (in vitro). General data from daily topical treatment for up to 30 days showed low efficacy for reducing lesions, and no clinical and parasitological cure was observed in the experimental animals. Thus, the [HB(pz)3]Cu(PCN) complex proved to be promising in in vitro studies against L. (V.) braziliensis, and should be further tested in new formulations and new experimental treatment schemes.
doi_str_mv 10.6084/m9.figshare.19920738
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_19920738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_19920738</sourcerecordid><originalsourceid>FETCH-LOGICAL-d918-bec052982dba42a33d55558a74eb7edbdbadc7b4737c366dda8353257b2cd85e3</originalsourceid><addsrcrecordid>eNo1kD9vgzAUxL10qNJ-gw4e2wEKNmB7rKL-QULKkt162I9gKWALrCh8-zpqc8u7dzrd8CPkpSzyppDV-6TywZ3WERbMS6VYIbh8JNjO9OLi4inMlrrbc0neRJfSjfqBAh234KO_OkONDwGX1_YtuSmc8UrhBG5eI7W4TD7NhNTq0K3jBLMDugY0Dtcn8jDAecXn_7sjx6_P4_4n6w7f7f6jy6wqZdajKWqmJLM9VAw4t3WSBFFhL9D2KbZG9JXgwvCmsRYkrzmrRc-MlTXyHan-Zi1EMC6iDoubYNl0WegbBD0pfYeg7xD4L68JWu8</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>In vitro and in vivo activity of a hypotoxic copper(I) complex against dermotropic Leishmania species</title><source>DataCite</source><creator>CHAGAS, Ana Flávia da Silva ; PORCHIA, Marina ; NASCIMENTO, Thaís Pinto ; CORREA, Carolina Nunes Souza ; BRASIL, Anny Maíza Vargas ; FRANCO, Antonia Maria Ramos</creator><creatorcontrib>CHAGAS, Ana Flávia da Silva ; PORCHIA, Marina ; NASCIMENTO, Thaís Pinto ; CORREA, Carolina Nunes Souza ; BRASIL, Anny Maíza Vargas ; FRANCO, Antonia Maria Ramos</creatorcontrib><description>ABSTRACT Cutaneous leishmaniasis is a disease caused by protozoa of the genus Leishmania and, currently, the treatment of first choice is meglumine antimoniate. However, due to its limited effectiveness and high toxicity, it is necessary to seek new active principles for leishmaniasis treatment. Metal complexes are gaining importance due to their effectiveness and low toxicity. In this context, the present study aimed to evaluate the in vitro and in vivo antileishmanial activity of the hypotoxic copper(I) complex [HB(pz)3]Cu(PCN). Four dermotropic species of Leishmania were tested with the metal complex and its effectiveness was determined through parasitic viability and infectivity rate, and cytotoxicity was determined using a redox dye (resazurin). For the in vivo tests, hamsters were infected and the lesions treated with a formulated ointment containing the complex, the effectiveness of which was assessed by measuring the diameter of the inoculum/snout location and determining the parasitic load. The results demonstrated moderate toxicity in murine macrophages and human monocytes and better efficacy in Leishmania (V.) braziliensis when compared to the other species tested, with a 50% reduction in the viability of promastigote and amastigote forms (in vitro). General data from daily topical treatment for up to 30 days showed low efficacy for reducing lesions, and no clinical and parasitological cure was observed in the experimental animals. Thus, the [HB(pz)3]Cu(PCN) complex proved to be promising in in vitro studies against L. (V.) braziliensis, and should be further tested in new formulations and new experimental treatment schemes.</description><identifier>DOI: 10.6084/m9.figshare.19920738</identifier><language>eng</language><publisher>SciELO journals</publisher><subject>Agricultural Biotechnology not elsewhere classified ; FOS: Agricultural biotechnology ; FOS: Biological sciences ; Microbiology not elsewhere classified ; Zoology</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1887</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.19920738$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHAGAS, Ana Flávia da Silva</creatorcontrib><creatorcontrib>PORCHIA, Marina</creatorcontrib><creatorcontrib>NASCIMENTO, Thaís Pinto</creatorcontrib><creatorcontrib>CORREA, Carolina Nunes Souza</creatorcontrib><creatorcontrib>BRASIL, Anny Maíza Vargas</creatorcontrib><creatorcontrib>FRANCO, Antonia Maria Ramos</creatorcontrib><title>In vitro and in vivo activity of a hypotoxic copper(I) complex against dermotropic Leishmania species</title><description>ABSTRACT Cutaneous leishmaniasis is a disease caused by protozoa of the genus Leishmania and, currently, the treatment of first choice is meglumine antimoniate. However, due to its limited effectiveness and high toxicity, it is necessary to seek new active principles for leishmaniasis treatment. Metal complexes are gaining importance due to their effectiveness and low toxicity. In this context, the present study aimed to evaluate the in vitro and in vivo antileishmanial activity of the hypotoxic copper(I) complex [HB(pz)3]Cu(PCN). Four dermotropic species of Leishmania were tested with the metal complex and its effectiveness was determined through parasitic viability and infectivity rate, and cytotoxicity was determined using a redox dye (resazurin). For the in vivo tests, hamsters were infected and the lesions treated with a formulated ointment containing the complex, the effectiveness of which was assessed by measuring the diameter of the inoculum/snout location and determining the parasitic load. The results demonstrated moderate toxicity in murine macrophages and human monocytes and better efficacy in Leishmania (V.) braziliensis when compared to the other species tested, with a 50% reduction in the viability of promastigote and amastigote forms (in vitro). General data from daily topical treatment for up to 30 days showed low efficacy for reducing lesions, and no clinical and parasitological cure was observed in the experimental animals. Thus, the [HB(pz)3]Cu(PCN) complex proved to be promising in in vitro studies against L. (V.) braziliensis, and should be further tested in new formulations and new experimental treatment schemes.</description><subject>Agricultural Biotechnology not elsewhere classified</subject><subject>FOS: Agricultural biotechnology</subject><subject>FOS: Biological sciences</subject><subject>Microbiology not elsewhere classified</subject><subject>Zoology</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2022</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1kD9vgzAUxL10qNJ-gw4e2wEKNmB7rKL-QULKkt162I9gKWALrCh8-zpqc8u7dzrd8CPkpSzyppDV-6TywZ3WERbMS6VYIbh8JNjO9OLi4inMlrrbc0neRJfSjfqBAh234KO_OkONDwGX1_YtuSmc8UrhBG5eI7W4TD7NhNTq0K3jBLMDugY0Dtcn8jDAecXn_7sjx6_P4_4n6w7f7f6jy6wqZdajKWqmJLM9VAw4t3WSBFFhL9D2KbZG9JXgwvCmsRYkrzmrRc-MlTXyHan-Zi1EMC6iDoubYNl0WegbBD0pfYeg7xD4L68JWu8</recordid><startdate>20220530</startdate><enddate>20220530</enddate><creator>CHAGAS, Ana Flávia da Silva</creator><creator>PORCHIA, Marina</creator><creator>NASCIMENTO, Thaís Pinto</creator><creator>CORREA, Carolina Nunes Souza</creator><creator>BRASIL, Anny Maíza Vargas</creator><creator>FRANCO, Antonia Maria Ramos</creator><general>SciELO journals</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20220530</creationdate><title>In vitro and in vivo activity of a hypotoxic copper(I) complex against dermotropic Leishmania species</title><author>CHAGAS, Ana Flávia da Silva ; PORCHIA, Marina ; NASCIMENTO, Thaís Pinto ; CORREA, Carolina Nunes Souza ; BRASIL, Anny Maíza Vargas ; FRANCO, Antonia Maria Ramos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d918-bec052982dba42a33d55558a74eb7edbdbadc7b4737c366dda8353257b2cd85e3</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Agricultural Biotechnology not elsewhere classified</topic><topic>FOS: Agricultural biotechnology</topic><topic>FOS: Biological sciences</topic><topic>Microbiology not elsewhere classified</topic><topic>Zoology</topic><toplevel>online_resources</toplevel><creatorcontrib>CHAGAS, Ana Flávia da Silva</creatorcontrib><creatorcontrib>PORCHIA, Marina</creatorcontrib><creatorcontrib>NASCIMENTO, Thaís Pinto</creatorcontrib><creatorcontrib>CORREA, Carolina Nunes Souza</creatorcontrib><creatorcontrib>BRASIL, Anny Maíza Vargas</creatorcontrib><creatorcontrib>FRANCO, Antonia Maria Ramos</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHAGAS, Ana Flávia da Silva</au><au>PORCHIA, Marina</au><au>NASCIMENTO, Thaís Pinto</au><au>CORREA, Carolina Nunes Souza</au><au>BRASIL, Anny Maíza Vargas</au><au>FRANCO, Antonia Maria Ramos</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>In vitro and in vivo activity of a hypotoxic copper(I) complex against dermotropic Leishmania species</title><date>2022-05-30</date><risdate>2022</risdate><abstract>ABSTRACT Cutaneous leishmaniasis is a disease caused by protozoa of the genus Leishmania and, currently, the treatment of first choice is meglumine antimoniate. However, due to its limited effectiveness and high toxicity, it is necessary to seek new active principles for leishmaniasis treatment. Metal complexes are gaining importance due to their effectiveness and low toxicity. In this context, the present study aimed to evaluate the in vitro and in vivo antileishmanial activity of the hypotoxic copper(I) complex [HB(pz)3]Cu(PCN). Four dermotropic species of Leishmania were tested with the metal complex and its effectiveness was determined through parasitic viability and infectivity rate, and cytotoxicity was determined using a redox dye (resazurin). For the in vivo tests, hamsters were infected and the lesions treated with a formulated ointment containing the complex, the effectiveness of which was assessed by measuring the diameter of the inoculum/snout location and determining the parasitic load. The results demonstrated moderate toxicity in murine macrophages and human monocytes and better efficacy in Leishmania (V.) braziliensis when compared to the other species tested, with a 50% reduction in the viability of promastigote and amastigote forms (in vitro). General data from daily topical treatment for up to 30 days showed low efficacy for reducing lesions, and no clinical and parasitological cure was observed in the experimental animals. Thus, the [HB(pz)3]Cu(PCN) complex proved to be promising in in vitro studies against L. (V.) braziliensis, and should be further tested in new formulations and new experimental treatment schemes.</abstract><pub>SciELO journals</pub><doi>10.6084/m9.figshare.19920738</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.19920738
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_19920738
source DataCite
subjects Agricultural Biotechnology not elsewhere classified
FOS: Agricultural biotechnology
FOS: Biological sciences
Microbiology not elsewhere classified
Zoology
title In vitro and in vivo activity of a hypotoxic copper(I) complex against dermotropic Leishmania species
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T23%3A39%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=CHAGAS,%20Ana%20Fl%C3%A1via%20da%20Silva&rft.date=2022-05-30&rft_id=info:doi/10.6084/m9.figshare.19920738&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_19920738%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true